Creative Medical Technology Holdings Inc
CELZ2.920USD
+0.050+1.74%
Fechamento 08/04, 16:00（ET）Cotações atrasadas em 15 min
7.54MValor de mercado
PerdaP/L TTM
Mais detalhes de Creative Medical Technology Holdings Inc Empresa
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company dedicated to the advancement of identifying and translating novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. The Company conducts substantially all of its commercial operations through its subsidiary, Creative Medical Technologies, Inc. Its products include AlloStem (CELZ-201-DDT) - allogenic human perinatal tissue derived cell program (clinical phase), ImmCelz (CELZ-100) - personalized supercharged immune therapy platform (pre-clinical trials), Type I Diabetes (CELZ-201 CREATE-1) - type I diabetes, Allostemspine Chronic Lower Back Pain (CELZ 201 ADAPT), Alova, CaverStem - erectile dysfunction treatment, FemCelz - female sexual function treatment, StemSpine - regenerative stem cell procedure for the treatment of degenerative disc disease (clinical trials), and OvaStem - stem cell therapy for premature ovarian failure.
Informações da empresa
Código da empresaCELZ
Nome da EmpresaCreative Medical Technology Holdings Inc
Data de listagemMay 01, 2009
CEOMr. Timothy Warbington
Número de funcionários4
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 01
Endereço211 E. Osborn Rd.
CidadePHOENIX
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal85012
Telefone14803992822
Sitehttps://creativemedicaltechnology.com/
Código da empresaCELZ
Data de listagemMay 01, 2009
CEOMr. Timothy Warbington
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Timothy Warbington
Mr. Timothy Warbington
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
12.21K
--
Mr. Donald Dickerson
Mr. Donald Dickerson
Chief Financial Officer, Senior Vice President, Director
Chief Financial Officer, Senior Vice President, Director
17.00
--
Mr. Michael H. Finger
Mr. Michael H. Finger
Independent Director
Independent Director
--
--
Mr. Bruce S. Urdang, Esq.
Mr. Bruce S. Urdang, Esq.
Independent Director
Independent Director
--
--
Ms. Susan Hegarty Snow
Ms. Susan Hegarty Snow
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Timothy Warbington
Mr. Timothy Warbington
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
12.21K
--
Mr. Donald Dickerson
Mr. Donald Dickerson
Chief Financial Officer, Senior Vice President, Director
Chief Financial Officer, Senior Vice President, Director
17.00
--
Mr. Michael H. Finger
Mr. Michael H. Finger
Independent Director
Independent Director
--
--
Mr. Bruce S. Urdang, Esq.
Mr. Bruce S. Urdang, Esq.
Independent Director
Independent Director
--
--
Ms. Susan Hegarty Snow
Ms. Susan Hegarty Snow
Independent Director
Independent Director
--
--
Detalhamento da receita
Sem dados
Sem dados
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: qui, 24 de jul
Atualizado em: qui, 24 de jul
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Armistice Capital LLC
5.72%
Creative Medical Health, Inc.
0.88%
Geode Capital Management, L.L.C.
0.71%
The Vanguard Group, Inc.
0.68%
HRT Financial LP
0.50%
Other
91.50%
Investidores
Investidores
Proporção
Armistice Capital LLC
5.72%
Creative Medical Health, Inc.
0.88%
Geode Capital Management, L.L.C.
0.71%
The Vanguard Group, Inc.
0.68%
HRT Financial LP
0.50%
Other
91.50%
Tipos de investidores
Investidores
Proporção
Hedge Fund
5.85%
Investment Advisor/Hedge Fund
1.42%
Corporation
0.88%
Investment Advisor
0.64%
Individual Investor
0.49%
Other
90.73%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
25
239.86K
9.28%
+97.57K
2025Q1
27
239.16K
9.28%
+93.67K
2024Q4
29
67.44K
3.86%
-172.00K
2024Q3
32
114.73K
8.54%
-150.07K
2024Q2
34
115.50K
8.55%
-269.83K
2024Q1
36
151.46K
11.09%
-154.43K
2023Q4
38
64.97K
4.67%
-273.04K
2023Q3
42
127.49K
15.08%
-223.19K
2023Q2
41
127.02K
15.07%
-210.98K
2023Q1
39
140.30K
16.02%
-112.96K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Armistice Capital LLC
148.00K
5.72%
+148.00K
--
Mar 31, 2025
Creative Medical Health, Inc.
22.70K
0.88%
--
--
Apr 15, 2025
Geode Capital Management, L.L.C.
18.27K
0.71%
+7.96K
+77.22%
Mar 31, 2025
The Vanguard Group, Inc.
17.63K
0.68%
--
--
Mar 31, 2025
HRT Financial LP
13.05K
0.5%
+13.05K
--
Mar 31, 2025
Warbington (Timothy)
12.21K
0.47%
--
--
Apr 15, 2025
Tower Research Capital LLC
3.15K
0.12%
+1.50K
+91.26%
Mar 31, 2025
Osaic Holdings, Inc.
1.26K
0.05%
+1.13K
+862.60%
Mar 31, 2025
Northern Trust Investments, Inc.
805.00
0.03%
+805.00
--
Dec 31, 2023
Ver Mais
ETFs Relacionados
Nome
Proporção
Sem dados
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Jun 09, 2023
Merger
10<1
Jun 09, 2023
Merger
10<1
Jun 09, 2023
Merger
10<1
Jun 09, 2023
Merger
10<1
Data
Tipo
Proporção
Jun 09, 2023
Merger
10<1
Jun 09, 2023
Merger
10<1
Jun 09, 2023
Merger
10<1
Jun 09, 2023
Merger
10<1
